Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | EIF2AK2 | P19525 | 1/20 | 0.41 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.41 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.41 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | GFER | P55789 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6103241 | 1.00 | SMN1; SMN2 (0.41) | SMN1; SMN2EIF2AK2CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL6103613 | 0.99 | GAA (0.41) | SMN1; SMN2EIF2AK2CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL6104091 | 0.99 | GAA (0.41) | SMN1; SMN2EIF2AK2CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL6103607 | 0.99 | GAA (0.41) | SMN1; SMN2EIF2AK2CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL6105716 | 0.99 | GAA (0.41) | SMN1; SMN2EIF2AK2CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL6104095 | 0.99 | GAA (0.41) | SMN1; SMN2EIF2AK2CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL6105724 | 0.99 | GAA (0.41) | SMN1; SMN2EIF2AK2CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL29952402 | 0.88 | LMNA (0.41) | SMN1; SMN2EIF2AK2CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL6106291 | 0.87 | BACE1 (0.43) | SMN1; SMN2ALDH1A1NPSR1PTPN1MAPT | |
| SCHEMBL6106286 | 0.87 | BACE1 (0.43) | SMN1; SMN2ALDH1A1NPSR1PTPN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060160864-A1 | Acrylamide derivative, process for producing the same, and use | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-07-20 | — | — | US | disclosed |
| EP-1593673-A1 | ACRYLAMIDE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE | Takeda Pharmaceutical Company Limited (JP) | 2005-11-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060160864-A1 | Acrylamide derivative, process for producing the same, and use | CCR5, MSR1, CCR2 | SMN1; SMN2 2871/4885EIF2AK2 479/4885CSNK2A2 2063/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.